
Arthrex received FDA clearance to use the Arthrex NanoScope operative arthroscopy system for pediatric orthopedics as well as laparoscopy.
NanoScope is a compact, high-resolution mobile imaging platform featuring the industry’s first high-definition, chip-on-tip camera — known as the NanoNeedle Scope — engineered specifically to meet the unique anatomical and procedural needs of pediatric patients.
The system can be used in common pediatric cases like general knee arthroscopy, meniscal treatments, anterior cruciate ligament reconstruction and general shoulder arthroscopy. The smaller scope is designed to minimize the potential risk of damaging anatomical structures upon entry along with neurovascular structures.
“This innovative and disruptive technology is transforming the way we approach diagnostic and least-invasive surgical treatments, and we are extremely proud to expand its indications to the field of pediatric orthopedics and laparoscopy,” said Arthrex President and Founder Reinhold Schmieding.
Source: Arthrex
Arthrex received FDA clearance to use the Arthrex NanoScope operative arthroscopy system for pediatric orthopedics as well as laparoscopy.
NanoScope is a compact, high-resolution mobile imaging platform featuring the industry's first high-definition, chip-on-tip camera — known as the NanoNeedle Scope — engineered specifically to meet the...
Arthrex received FDA clearance to use the Arthrex NanoScope operative arthroscopy system for pediatric orthopedics as well as laparoscopy.
NanoScope is a compact, high-resolution mobile imaging platform featuring the industry’s first high-definition, chip-on-tip camera — known as the NanoNeedle Scope — engineered specifically to meet the unique anatomical and procedural needs of pediatric patients.
The system can be used in common pediatric cases like general knee arthroscopy, meniscal treatments, anterior cruciate ligament reconstruction and general shoulder arthroscopy. The smaller scope is designed to minimize the potential risk of damaging anatomical structures upon entry along with neurovascular structures.
“This innovative and disruptive technology is transforming the way we approach diagnostic and least-invasive surgical treatments, and we are extremely proud to expand its indications to the field of pediatric orthopedics and laparoscopy,” said Arthrex President and Founder Reinhold Schmieding.
Source: Arthrex
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.